Portal Vein Embolization and Ligation for Extended Hepatectomy

Soumil Vyas1, Sheraz R. Markar1, Stefano Partelli2, Tim Fotheringham3, Daniel Low3, Charles Imber1, Massimo Malagó1, Hemant M. Kocher2
1Hepato-biliary and Pancreatic Surgery Unit, Royal Free Hospital, London, UK
2Hepato-biliary and Pancreatic Surgery Unit, Royal London Hospital, London, UK
3Interventional Radiology Barts and the London HPB Centre, The Royal London Hospital, London, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1271–1280

Liu H, Zhu S (2009) Present status and future perspectives of preoperative portal vein embolization. Am J Surg 197(5):686–690, Review

Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H (2000) Resection of nonresectable liver metastases from colorectal cancerafter percutaneous portal vein embolization. Ann Surg 231(4):480–486

Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, Sugimachi K (1999) Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 188(3):304–309

Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN (2002) Extendedhepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137(6):675–680, discussion 680–1

Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243(3):364–372

Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351(4):337–345

Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):2335–2342

Sharma S, Camci C, Jabbour N (2008) Management of hepatic metastasis from colorectal cancers: an update. J Hepato-Biliary-Pancreat Surg 15(6):570–580

Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–406, discussion 406–7

Choti MA, Bowman HM, Pitt HA, Sosa JA, Sitzmann JV, Cameron JL, Gordon TA (1998) Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg 2(1):11–20

Melendez J, Ferri E, Zwillman M, Fischer M, DeMatteo R, Leung D, Jarnagin W, Fong Y, Blumgart LH (2001) Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 192(1):47–53

Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3):309–318, discussion 318–21

Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90(5):567–574

Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240(6):1037–1049, discussion 1049–51

Rees M, Plant G, Bygrave S (1997) Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84(8):1136–1140

Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, Sofocleous CT, D’Angelica M, Getrajdman GI, DeMatteo R, Kemeny NE, Fong Y (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247(3):451–455

Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghémard O, Levi F, Bismuth H (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240(4):644–657, discussion 657–8

Rous P, Larimore LD (1920) Relation of the portal blood flow to liver maintenance: a demonstration of liver atrophy conditional on compression. J Exp Med 31:609–632

Bax HR, Mansens BJ, Schalm L (1956) Atrophy of the liver after occlusion of the bile ducts or portal vein and compensatory hypertrophy of the unoccluded portion and its clinical importance. Gastroenterology 31(2):131–155

Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, Yamazaki S, Hasegawa H, Ozaki H (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107(5):521–527

Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10(5):803–808

Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R (1993) Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 17(1):109–115

Wakabayashi H, Ishimura K, Okano K, Karasawa Y, Goda F, Maeba T, Maeta H (2002) Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery 131(1):26–33

Di Stefano DR, de Baere T, Denys A et al (2005) Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234:625–630

Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, Denys A, Sauvanet A (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237(2):208–217

Cotroneo AR, Innocenti P, Marano G, Legnini M, Iezzi R (2009) Pre-hepatectomy portal vein embolization: single center experience. Eur J Surg Oncol 35(1):71–78

Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, Makuuchi M, Kawasaki S (1999) Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29(4):1099–1105

de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V (1996) Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 24(6):1386–1391

Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D (2008) Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery 143(4):476–482

Makuuchi M, Kosuge T, Lygidakis NJ (1991) New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma—an old problem revisited. Hepatogastroenterology 38(4):329–336

Seo DD, Lee HC, Jang MK, Min HJ, Kim KM, Lim YS, Chung YH, Lee YS, Suh DJ, Ko GY, Lee YJ, Lee SG (2007) Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization. Ann Surg Oncol 14(12):3501–3509

Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC (2008) Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol 15(7):1908–1917

Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN (2007) Portal vein embolization before major hepatectomy and its effects On regeneration, resectability and outcome. Br J Surg 94(11):1386–1394

Capussotti L, Muratore A, Baracchi F, Lelong B, Ferrero A, Regge D, Delpero JR (2008) Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 143(10):978–982, discussion 982

Pamecha V, Glantzounis G, Davies N, Fusai G, Sharma D, Davidson B (2009) Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol 16(5):1202–1207

de Baere T, Teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, Auperin A, Goere D, Elias D, Hechelhammer L (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17(8):2081–2089

Wicherts DA, de Haas RJ, Andreani P, Sotirov D, Salloum C, Castaing D, Adam R, Azoulay D (2010) Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 97(2):240–250

Ratti F, Soldati C, Catena M, Paganelli M, Ferla G, Aldrighetti L (2010) Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients. Updates Surg 62(3-4):153–159

Yoo H, Ko GY, Gwon DI, Kim JH, Yoon HK, Sung KB, Kim N, Lee J (2009) Preoperative portal vein embolization using an amplatzer vascular plug. Eur Radiol 19(5):1054–1061

Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG, Schulte am Esch J, Rogiers X (2002) Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 6(6):905–913, discussion 913

Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V, Belghiti J (2008) Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 12(2):297–303

Are C, Iacovitti S, Prete F, Crafa FM (2008) Feasibility of laparoscopic portal vein ligation prior to major hepatectomy. HPB (Oxford) 10(4):229–233

Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J (2003) Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197(1):164–170

Tsuge H, Mimura H, Kawata N, Orita K (1994) Right portal embolization Before extended right hepatectomy using laparoscopic catheterization of the ileocolic vein: a prospective study. Surg Laparosc Endosc 4(4):258–263

Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR (2008) Preoperative portal vein embolization for major liver resection: a meta analysis. Ann Surg 247(1):49–57

Perarnau JM, Daradkeh S, Johann M, Deneuville M, Weinling P, Coniel C (2003) Transjugular preoperative portal embolization (TJPE) a pilot study. Hepatogastroenterology 50(51):610–613

Madoff DC, Hicks ME, Vauthey JN, Charnsangavej C, Morello FA Jr, Ahrar K, Wallace MJ, Gupta S (2002) Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics 22(5):1063–1076, Review

Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127(5):512–519

Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA Jr, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN (2005) Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16:215–225

Capussotti L, Muratore A, Ferrero A, Anselmetti GC, Corgnier A, Regge D (2005) Extension of right portal vein embolization to segment IV portal branches. Arch Surg 140(11):1100–1103

Yokoyama Y, Nagino M, Nimura Y (2007) Mechanisms of hepatic regeneration Following portal vein embolization and partial hepatectomy: a review. World J Surg 31(2):367–374, Review

Truant S, Oberlin O, Sergent G, Lebuffe G, Gambiez L, Ernst O, Pruvot FR (2007) Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204(1):22–33

Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM, Wei SH, Vauthey JN (2008) Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg 12(1):123–128

Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191(1):38–46

Abdalla EK, Hicks ME, Vauthey JN (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88(2):165–175, Review

Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26(5):1176–1181

Kokudo N, Makuuchi M (2004) Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin N Am 84(2):643–657, Review

Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF, Vauthey JN (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237(5):686–691, discussion 691–3

Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Hayakawa N, Yamamoto H (1995) Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 21(2):434–439

Elias D, Debaere T, Roche A, Bonvallot S, Lasser P (1998) Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver. Hepatogastroenterology 45(19):170–177

Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, Emile JF, Bismuth H (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232(5):665–672

Oussoultzoglou E, Bachellier P, Rosso E, Scurtu R, Lucescu I, Greget M, Jaeck D (2006) Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg 244(1):71–79

de Baere T, Denys A, Madoff DC (2007) Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol 10(1):67–78, Review

Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94(11):1386–1394

Elias D, De Baere T, Roche A, Mducreux, Leclere J, Lasser P (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86(6):784–788

Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Ohta K, Yamaguchi T, Matsubara T, Takahashi T, Nakajima T, Muto T, Ikari T, Yanagisawa A, Kato Y (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34(2):267–272

Boerma EJ (1990) Research into the results of resection of hilar bile duct cancer. Surgery 108(3):572–580, Review

Weitz J, Koch M, Kienle P, Schrödel A, Willeke F, Benner A, Lehnert T, Herfarth C, von Knebel Doeberitz M (2000) Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg 232(1):66–72

Koch M, Kienle P, Hinz U, Antolovic D, Schmidt J, Herfarth C, von Knebel Doeberitz M, Weitz J (2005) Detection of hematogenous tumor cell dissemination Predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg 241(2):199–205

Kienle P, Koch M, Autschbach F, Benner A, Treiber M, Wannenmacher M, von Knebel Doeberitz M, Büchler M, Herfarth C, Weitz J (2003) Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer. Ann Surg 238(3):324–330, discussion 330–1

Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 232(6):777–785